-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 KWmOVGOglOwHdZb/41u98/htpssQ8TSxh7MixD181RSqZmNZg+KaxuFHAqhoTTrS
 /b2mlsCBMMNxu4oMXbGqmg==

<SEC-DOCUMENT>0000943440-08-000480.txt : 20081103
<SEC-HEADER>0000943440-08-000480.hdr.sgml : 20081103
<ACCEPTANCE-DATETIME>20081103143223
ACCESSION NUMBER:		0000943440-08-000480
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20081103
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20081103
DATE AS OF CHANGE:		20081103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0330

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		081157103

	BUSINESS ADDRESS:	
		STREET 1:		1441 SW 29 AVENUE
		CITY:			POMPANO BEACH
		STATE:			FL
		ZIP:			33069
		BUSINESS PHONE:		9549794788

	MAIL ADDRESS:	
		STREET 1:		1441 SW 29 AVENUE
		CITY:			POMPANO BEACH
		STATE:			FL
		ZIP:			33069
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k110308.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>IMPAX LABORATORIES INC (Form: 8-K, Received: 01/08/2007 14:15:22)</TITLE>
<META NAME="author" CONTENT="EDGAR Online HTML to RTF Converter. Version 3.0">
<META NAME="date" CONTENT="11/03/2008">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></P>
<P style="line-height:15.5pt; margin-top:15px; margin-bottom:0px; font-family:Arial; font-size:13.5pt" align=center><B>FORM 8-K</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center>Date of report (Date of earliest event reported): November 3, 2008</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR style="font-size:0"><TD width=24.267></TD><TD width=129.333></TD><TD width=153.6></TD><TD width=153.6></TD><TD width=153.6></TD><TD width=153.6></TD></TR>
<TR><TD valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=743.733 colspan=5><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>PetMed Express, Inc.<BR>
</U></B> (Exact name of registrant as specified in its charter)</P>
</TD></TR>
<TR><TD style="background-color:#FFFFFF" valign=top width=153.6 colspan=2><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P>&nbsp;</P></TD></TR>
<TR><TD style="background-color:#FFFFFF" valign=top width=153.6 colspan=2><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>Florida</U></B></P>
</TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>000-28827</U></B></P>
</TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>65-0680967</U></B></P>
</TD></TR>
<TR><TD style="background-color:#FFFFFF" valign=top width=153.6 colspan=2><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(State or other jurisdiction<BR>
of incorporation)</P>
</TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(Commission<BR>
File Number)</P>
</TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(I.R.S. Employer<BR>
Identification No.)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR style="font-size:0"><TD width=768></TD></TR>
<TR><TD valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>1441 S.W. 29<SUP>th</SUP> Avenue, &nbsp;Pompano Beach, FL &nbsp;33069</U></B></P>
</TD></TR>
<TR><TD valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(Address of principal executive offices) (Zip Code)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR style="font-size:0"><TD width=751.4></TD><TD width=16.6></TD></TR>
<TR><TD style="background-color:#FFFFFF" valign=top width=751.4><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>(954) 979-5995</U></B></P>
</TD><TD style="background-color:#FFFFFF" valign=top width=16.6><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD style="background-color:#FFFFFF" valign=top width=751.4><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(Registrant&#146;s telephone number, including area code)</P>
</TD><TD style="background-color:#FFFFFF" valign=top width=16.6><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR style="font-size:0"><TD width=768></TD></TR>
<TR><TD valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>Not Applicable</U></B></P>
</TD></TR>
<TR><TD valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(Former name or former address, if changed since last report)</P>
</TD></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR style="font-size:0"><TD width=24.267></TD><TD width=743.733></TD></TR>
<TR><TD valign=top width=24.267><P style="margin:0px; font-family:Wingdings">&#168;</P>
</TD><TD valign=top width=743.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
</TD></TR>
<TR><TD valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=743.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=24.267><P style="margin:0px; font-family:Wingdings">&#168;</P>
</TD><TD valign=top width=743.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
</TD></TR>
<TR><TD valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=743.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=24.267><P style="margin:0px; font-family:Wingdings">&#168;</P>
</TD><TD valign=top width=743.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
</TD></TR>
<TR><TD valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=743.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=24.267><P style="margin:0px; font-family:Wingdings">&#168;</P>
</TD><TD valign=top width=743.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
</TD><A NAME="FIS_OTHER_EVENTS"></A></TR>
</TABLE>
<P style="margin-top:12.533px; margin-bottom:0px"><BR>
<BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px" noshade size=1.333>
<P style="margin-top:12.533px; margin-bottom:0px; font-family:Arial; page-break-before:always"><B>Item 7.01&nbsp;&nbsp;&nbsp;Regulation FD Disclosure.</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial"><B>Item 8.01&nbsp;&nbsp;&nbsp;Other Events.</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:24px; font-family:Arial" align=justify>On November 3, 2008, PetMed Express, Inc. issued a press release announcing that the Board of Directors of PetMed Express, Inc. has approved a second share repurchase program of up to $20 million, effective immediately. &nbsp;This program is intended to be implemented through purchases made from time to time in either the open market or through private transactions at the Company&#146;s discretion, subject to market conditions and other factors, in accordance with Securities and Exchange Commission requirements. &nbsp;There can be no assurances as to the precise number of shares that will be repurchased under the share repurchase program, and the Company may discontinue the share repurchase program at any time subject to compliance with applicable regulatory requirements. &nbsp;Shares purchased pursuant to the share repurchase program will either be cancelled or held in the Company&#146;s treasury. &nbsp;A copy of the press release is a
ttached hereto as Exhibit 99.1 and is incorporated herein by reference.</P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial"><B>Item 9.01&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR style="font-size:0"><TD width=77.733></TD><TD width=24.2></TD><TD width=666.067></TD></TR>
<TR><TD valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial">(d)</P>
</TD><TD valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial">Exhibits.</P>
</TD></TR>
<TR><TD valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial">99.1 &#150; Press release dated November 3, 2008.</P>
</TD><A NAME="FIS_EXHIBIT_INDEX"></A></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center><B>EXHIBIT INDEX</B></P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR style="font-size:0"><TD width=80.8></TD><TD width=17.133></TD><TD width=652.933></TD><TD width=17.133></TD></TR>
<TR><TD valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial"><U>Exhibit No.</U></P>
</TD><TD valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial"><U>Description</U></P>
</TD><TD valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD style="background-color:#FFFFFF" valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial">99.1</P>
</TD><TD style="background-color:#FFFFFF" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD style="background-color:#FFFFFF" valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial">Press release dated November 3, 2008</P>
</TD><TD style="background-color:#FFFFFF" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><A NAME="FIS_SIGNATURES"></A></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center><B>SIGNATURES</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial">Dated: November 3, 2008</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<DIV align=right><TABLE style="font-size:10pt" cellspacing=0><TR style="font-size:0"><TD width=383.333></TD><TD width=46.4></TD><TD width=338.267></TD></TR>
<TR><TD valign=top width=383.333><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=384.667 colspan=2><P style="margin:0px; padding-right:2.4px; font-family:Arial">PETMED EXPRESS, INC.</P>
</TD></TR>
<TR><TD valign=top width=383.333><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=338.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=383.333><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial">By:</P>
</TD><TD valign=top width=338.267><P style="margin:0px; padding-right:1.067px; font-family:Arial"><U>/s/ Bruce S. Rosenbloom</U></P>
</TD></TR>
<TR><TD valign=top width=383.333><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial">Name:</P>
</TD><TD valign=top width=338.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">Bruce S. Rosenbloom</P>
</TD></TR>
<TR><TD valign=top width=383.333><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial">Title:</P>
</TD><TD valign=top width=338.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">Chief Financial Officer</P>
</TD></TR>
<TR><TD valign=top width=383.333><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD valign=top width=338.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
</TABLE></DIV>
<P style="margin-top:15px; margin-bottom:0px"><BR></P>
<P style="margin-top:15px; margin-bottom:0px"><BR>
<BR></P>
<P style="margin:0px; font-family:Arial" align=center>2</P>
<P style="margin:0px"><BR></P>
</BODY>
<!-- EDGAR Validation Code: 3A82F665 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Exhibit 99</TITLE>
<META NAME="author" CONTENT="Karen Fornash">
<META NAME="date" CONTENT="11/03/2008">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-right:1.067px; font-family:Arial" align=right>Exhibit 99.1</P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-family:Arial; font-size:11pt" align=justify><B>PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES A SECOND $20 MILLION SHARE REPURCHASE PROGRAM</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-right:6px; font-family:Arial" align=justify>Pompano Beach, Florida, November 3, 2008 - The Board of Directors of PetMed Express, Inc. (NASDAQ:PETS) has approved a second share repurchase program of up to $20 million, effective immediately. &nbsp;This program is intended to be implemented through purchases made from time to time in either the open market or through private transactions at the Company&#146;s discretion, subject to market conditions and other factors, in accordance with Securities and Exchange Commission requirements. &nbsp;The Company still has approximately $2.8 million remaining from its initial $20 million repurchase plan, under which the Company has already repurchased approximately 1.4 million shares for approximately $17.2 million, an average of $12.36 per share. &nbsp;As of November 3, 2008, there are approximately 23.5 million shares of PetMed Express, Inc. common stock outstanding.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-right:6px; font-family:Arial" align=justify>&#147;The authorization from the Board to continue to repurchase shares is an indication of our Company&#146;s financial strength and demonstrates the confidence we have in our Company,&#148; commented Menderes Akdag, President and CEO of PetMed Express, Inc. &nbsp;&#147;Fortunately, the continued cash productivity of our business model enables us to actively invest cash in areas that we believe will drive future value for shareholders. &nbsp;Our share repurchase plans demonstrate our continued commitment to deliver long-term shareholder value.&#148;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-right:6px; font-family:Arial" align=justify>Founded in 1996, PetMed Express is America&#146;s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at <FONT COLOR=#0000FF><U>www.1800petmeds.com</U></FONT>.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-right:6px; font-family:Arial" align=justify>This press release may contain &#147;forward-looking&#148; statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company&#146;s ability to meet the objectives included in its business plan. &nbsp;Important factors that could cause results to differ materially from those indicated by such &#147;forward-looking&#148; statements are set forth in Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2008. &nbsp;The Company&#146;s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-right:6px; font-family:Arial" align=justify>For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-right:6px; font-family:Arial" align=center>###</P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; padding-right:6px; font-family:Arial" align=center>Exhibit 99.1 Page 1 of 1</P>
<P style="margin:0px"><BR></P>
</BODY>
<!-- EDGAR Validation Code: 05621D6F -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
